✦ LIBER ✦

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

✍ Scribed by Brent A. Neuschwander-Tetri; Stephen H. Caldwell

Book ID: 111722225
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 268 KB
Volume: 37
Category: Article
ISSN: 0270-9139
DOI: 10.1053/jhep.2003.50193

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrections: Nonalcoholic steatohepatiti

Corrections: Nonalcoholic steatohepatitis: Summary of an AASLD single topic conference

✍ Brent A. Neuschwander-Tetri; Stephen H. Caldwell 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 17 KB

Hepatic fibrosis 2006: Report of the thi

Hepatic fibrosis 2006: Report of the third AASLD Single Topic Conference

✍ Scott L. Friedman; Don C. Rockey; D. Montgomery Bissell 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

The third American Associated for the Study of Liver Diseases (AASLD)-sponsored Single Topic Conference on hepatic fibrosis was held in June 2006. The conference was both international, with 6 countries represented, and cross-disciplinary, linking the basic molecular and cellular biology of fibrogen

Advances in hepatic transport: Molecular

Advances in hepatic transport: Molecular mechanisms, genetic disorders, and treatment. A summary of the 1998 AASLD single topic conference

✍ Allan W. Wolkoff; Frederick J. Suchy; Richard H. Moseley; Peter J. Meier; John L 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

Mechanisms and therapy of hepatic fibros

Mechanisms and therapy of hepatic fibrosis: Report of the AASLD single topic basic research conference

✍ Scott L. Friedman; Jacquelyn J. Maher; D.Montgomery Bissell 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Drug-induced liver injury: Summary of a

Drug-induced liver injury: Summary of a single topic clinical research conference

✍ Paul B. Watkins; Leonard B. Seeff 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

Idiosyncratic drug induced liver injury (DILI) remains poorly understood. It is assumed that the affected individuals possess a rare combination of genetic and non genetic factors that, if identified, would greatly improve understanding of the underlying mechanisms. This single topic conference brou

Hepatitis C. Development of new drugs an

Hepatitis C. Development of new drugs and clinical trials: Promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27–March 1, 2003

✍ Jean-Michel Pawlotsky; John G. McHutchison 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB

hronic hepatitis C virus (HCV) infection affects a large number of patients worldwide. While our current therapies (Table ) are effective in approximately 50% of patients, therapy is costly, prolonged, and associated with significant side effects, and it is not suitable for certain groups of patient